SCHEMBL28339596

SCHEMBL28339596

COC(c1ccc(-c2cnc(NC(C)C)n(C)c2=O)nc1C)c1c[nH]c2ncccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 3/20 0.44
▸ PDGFRB P09619 2/20 0.44
▸ PDGFRA P16234 2/20 0.44
▸ FLT3 P36888 2/20 0.44
▸ LCK P06239 1/20 0.44
▸ KIT P10721 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ PTK6 Q13882 1/20 0.44
▸ MET P08581 3/20 0.38
▸ CDK2 P24941 6/20 0.33
▸ CDK9 P50750 5/20 0.33
▸ CCNT1 O60563 4/20 0.33
▸ CCNA2 P20248 4/20 0.33
▸ CDC7 O00311 5/20 0.33
▸ DBF4 Q9UBU7 3/20 0.33
▸ DYRK1A Q13627 3/20 0.32
▸ MAP2K1 Q02750 1/20 0.32
▸ MAP4K4 O95819 2/20 0.32
▸ PIM1 P11309 2/20 0.32
▸ PRKACA P17612 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21872992 0.88 CSF1R (0.44) CSF1RPDGFRBPDGFRAFLT3LCK
SCHEMBL21873003 0.80 GPR84 (0.45) CSF1RPDGFRBPDGFRAFLT3LCK
SCHEMBL21977192 0.79 CSF1R (0.43) CSF1RPDGFRBPDGFRAFLT3LCK
SCHEMBL21965132 0.79 CSF1R (0.42) CSF1RPDGFRBPDGFRAFLT3LCK
SCHEMBL21873122 0.77 CSF1R (0.44) CSF1RPDGFRBPDGFRAFLT3LCK
SCHEMBL21873037 0.76 CSF1R (0.43) CSF1RPDGFRBPDGFRAFLT3LCK
SCHEMBL21873007 0.72 MAP2K1 (0.43) FLT3METCDK2CDK9CDC7
SCHEMBL30825676 0.71 CSF1R (0.54) CSF1RPDGFRBPDGFRAFLT3LCK
SCHEMBL29222872 0.71 CSF1R (0.54) CSF1RPDGFRBPDGFRAFLT3LCK
SCHEMBL21872975 0.71 CCNB2 (0.38) CSF1RFLT3METCDK2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110461841-A A kind of azepine aryl derivatives, preparation method and application with CSF1R inhibitory activity ABBISKO THERAPEUTICS CO LTD 2019-11-15 — — CN disclosed
Send feedback